Ayr Wellness Inc. (AYRWF) — SEC Filings
Ayr Wellness Inc. (AYRWF) — 45 SEC filings. Latest: 6-K (Nov 26, 2025). Includes 43 6-K, 1 SC 13G, 1 SC 13G/A.
View Ayr Wellness Inc. on SEC EDGAR
Overview
Ayr Wellness Inc. (AYRWF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Nov 17, 2025: Ayr Wellness Inc. filed a Form 6-K on November 17, 2025, reporting for the month of November 2025. The filing includes a news release dated November 17, 2025, as Exhibit 99.1. Donna Granato, Interim Chief Financial Officer, signed the report on behalf of Ayr Wellness Inc.
Sentiment Summary
Across 45 filings, the sentiment breakdown is: 7 bullish, 38 neutral. The dominant filing sentiment for Ayr Wellness Inc. is neutral.
Filing Type Overview
Ayr Wellness Inc. (AYRWF) has filed 43 6-K, 1 SC 13G, 1 SC 13G/A with the SEC between Feb 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (45)
Risk Profile
Risk Assessment: Of AYRWF's 41 recent filings, 0 were flagged as high-risk, 20 as medium-risk, and 21 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Donna Granato
- Steven M. Cohen
- Brad Asher
- George Denardo
- David Frederick
- Jonathan Sandelman
- David Goubert
Top Tags
sec-filing (7) · 6-K (6) · news-release (6) · reporting (5) · financial-results (5) · restructuring (4) · debt (4) · management-change (4) · earnings (4) · cannabis (4)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Commission File Number | 333-253466 | Identifies the specific SEC filing record for Ayr Wellness Inc. |
| Period of Report | 20250331 | Indicates the financial period the report pertains to. |
| Filing Date | 20250912 | The date the report was officially submitted to the SEC. |
| Registration Statement File Number | 333-278161 | Links the incorporated exhibits to a broader registration filing. |
| Debt Reduction | ~$100 million | Resulting from the conversion of a multi-tranche instrument into equity. |
| Warrant Strike Price | $9.07 | The exercise price of the share purchase warrants that expired. |
| Q1 Revenue | $118.0 Mi | Revenue for the first quarter of 2024 |
| Q/Q Revenue Growth | 3% | Quarter-over-quarter increase in revenue |
| Senior Unsecured Notes Offering | $125M | Upsized amount providing additional capital for the company. |
| Debt retired or extended | US$400 million | Represents the total amount of debt whose maturity was pushed out, significantly reducing immediate financial pressure. |
| New debt maturity year | 2026 | Indicates when most of Ayr Wellness's debt will now mature, providing a two-year extension from 2024. |
| SVS Shares issued to 2024 Senior Noteholders | 29 million | Part of the consideration for extending the 2024 Senior Notes. |
| SVS Shares issued to Backstop Provider | 5 million | Issued in connection with the plan of arrangement. |
| Anti-Dilutive Warrants issued | 23 million | Distributed to shareholders of record as of February 5, 2024, to mitigate dilution from the share issuances. |
| New capital raised | US$40 million | Additional funds secured through the issuance of new Senior Notes, bolstering the company's liquidity. |
Forward-Looking Statements
- {"claim":"Ayr Wellness will release its Q4 and full-year 2023 financial results prior to the March 13th conference call.","entity":"Ayr Wellness Inc.","targetDate":"March 13, 2024","confidence":"high"}
- {"claim":"The stock price of Ayr Wellness (AYR.A, AYRWF) may experience volatility around the March 13th earnings call.","entity":"Ayr Wellness Inc.","targetDate":"March 13, 2024","confidence":"medium"}
- {"claim":"Ayr Wellness's stock price will see increased stability due to reduced immediate debt pressure.","entity":"Ayr Wellness Inc.","targetDate":"Q2 2024","confidence":"medium"}
- {"claim":"The company will focus on operational improvements and cash flow generation now that debt maturities are extended.","entity":"Ayr Wellness Inc.","targetDate":"Q3 2024","confidence":"high"}
- {"claim":"The issuance of Anti-Dilutive Warrants will partially offset the dilutive effect of SVS Shares on existing shareholders.","entity":"Ayr Wellness Inc. shareholders","targetDate":"Immediate","confidence":"high"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Ayr Wellness Inc. (AYRWF)?
Ayr Wellness Inc. has 45 recent SEC filings from Feb 2024 to Nov 2025, including 43 6-K, 1 SC 13G, 1 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of AYRWF filings?
Across 45 filings, the sentiment breakdown is: 7 bullish, 38 neutral. The dominant sentiment is neutral.
Where can I find Ayr Wellness Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ayr Wellness Inc. (AYRWF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ayr Wellness Inc.?
Financial highlights for Ayr Wellness Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for AYRWF?
Investment thesis data for AYRWF will be available once enriched filings are processed.
Who are the key executives at Ayr Wellness Inc.?
Key executives identified across Ayr Wellness Inc.'s filings include Donna Granato, Steven M. Cohen, Brad Asher, George Denardo, David Frederick and 2 others.
What are the main risk factors for Ayr Wellness Inc. stock?
Of AYRWF's 41 assessed filings, 0 were flagged high-risk, 20 medium-risk, and 21 low-risk.
What are recent predictions and forward guidance from Ayr Wellness Inc.?
Recent forward-looking statements from Ayr Wellness Inc. include guidance on {"claim":"Ayr Wellness will release its Q4 and full-year 2023 financial results prior to the March 13th conference call. and 4 other predictions.